Trypsin is a proteolytic enzyme that is commonly used in bioprocessing applications and cell culture studies to detach adherent cells from the surface of a laboratory vessel like a cell culture flask or petri dish. In the cell culture process, trypsin is used to detach adherent cultured cells from the walls of vessels so that they can be passaged or subcultured. Some of the main advantages of trypsin include high clearing activity and minimal proteolytic degradation of membrane proteins. With the growing adoption of tissue engineering and regenerative medicine approaches, the demand for cell-based research and therapies is rising rapidly. This increased focus on cell culture studies is expected to drive the demand for trypsin as it is extensively used in passaging and subculturing of adherent cell lines in laboratories.

The global trypsin market is estimated to be valued at US$ 42.95 million in 2021 and is expected to exhibit a CAGR of 4.3% over the forecast period 2021 to 2028.

Key Takeaways
Key players operating in the trypsin market are Promega Corporation, Merck KgaA, Geno Technology Inc., USA., Thermo Fisher Scientific Inc., SignalChem Biotech Inc., Takara Bio Inc., Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd., and BBI Solutions 

Trypsin Market Growth from cell-based research applications is a major factor driving the market. Cell culture studies have wide applications in various areas including cancer research, stem cell therapy, tissue engineering, and drug discovery. With rising R&D investments in life sciences, the demand for cell-based research is increasing significantly.

Technological advancements are playing a key role in expanding the potential applications of trypsin. Recombinant trypsin is gaining popularity as it provides high specificity and longer shelf life compared to animal-derived trypsin. Automated cell passaging systems that require minimal manual intervention are also helping increase efficiency and throughput of cell culture processes.

Market Trends

Outsourcing of bioprocessing activities- With growing workload, many research organizations and biopharma companies are outsourcing bioprocess development and manufacturing activities to contract development and manufacturing organizations (CDMOs). This is creating strong demand for trypsin from CDMOs.

Shift towards single-use technologies- To avoid cross-contamination risks and for improved operational flexibility, biomanufacturers are increasingly adopting single-use bioreactors, vessels, and piping. This transition to single-use is benefiting the trypsin market.

Market Opportunities
Emerging markets in Asia Pacific and Latin America promise significant growth opportunities. These regions are witnessing substantial investments to build local biosimilar manufacturing capabilities and set up novel drug development centers. This will fuel local demand for trypsin.

Adoption of automated cell therapy manufacturing presents an opportunity. Automated solutions minimize manual errors and ensure reproducibility in cell therapy manufacturing. Trypsin has an important role to play in automated passaging of adherent cell lines.

Impact of COVID-19 on Trypsin Market Growth

The COVID-19 pandemic has significantly impacted the trypsin market. During the initial lockdown phases in 2020, production and supply chain activities were disrupted. This led to a short-term decline in market growth. As the pandemic spread, several end use industries that utilize trypsin such as food and beverage, pharmaceutical and biotechnology witnessed a downfall in demand initially.

However, as the effects of the pandemic prolonged, the demand for trypsin increased from the pharmaceutical sector. With the outbreak, there was a surge in research related to drug development and vaccine manufacturing. Trypsin found wide applications in cancer research, viral activation, immune assay development and other areas. The need for mass vaccine production once a vaccine was developed further boosted demand. Several market players increased production capacities to fulfill the unprecedented demand from the pharmaceutical industry.

With restrictions now being lifted gradually, other end use sectors are also recovering. The food industry is witnessing higher demand as economic activities have resumed. This growth in diverse application areas is projected to help the trypsin market witness steady growth in the coming years. However, potential future waves of the pandemic still remain a challenge. Market players will need to focus on maintaining flexible supply chains and ensuring steady supply to cater to shifts in demand patterns.

Geographical Regions with High Trypsin Market Concentration

North America represents one of the largest and most concentrated markets for trypsin globally. This can be attributed to presence of several pharmaceutical and biotech giants in US and Canada who are major consumers of trypsin. Extensive research and development activities underway in the region generate strong demand. Furthermore, rising health expenditure and increasing investments in drug development and medical research over the years have further augmented market growth.

The Fastest Growing Regional Market for Trypsin

Asia Pacific is poised to be the fastest growing trypsin market in terms of value over the forecast period. This can be credited to increasing investments by international as well as local pharmaceutical companies in countries such as India and China where manufacturing and R&D hubs are being set up. Additionally, rising incomes, growing medical tourism and extensive healthcare reforms underway are augmenting pharma sector growth, thereby boosting trypsin demand.

Get more insights on, Trypsin Market

Get these Report in Japanese Language:

トリプシン市場

Get these Report in Korean Language:

트립신 마켓

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)